Here, we found that TNFRSF10B, along with a vesicular trafficking regulator protein, YIPF2, were upregulated after treatment with pemetrexed (PEM) in NSCLC cells. This evidence concerns the gene TNFRSF10B and non-small cell lung carcinoma.